---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-014618"
form_type: "8-K"
ticker: "QSI"
cik: "0001816431"
company_name: "Quantum-Si Inc"
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T10:19:10.823044+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Quantum-Si appoints former Illumina executive Paula Dowdy to board

## Summary
- Paula Dowdy appointed to board effective March 21, 2024.
- She has over 35 years experience including SVP/GM EMEA at Illumina and 20+ years at Cisco.
- Board determined Dowdy is independent under Nasdaq rules; she will receive standard non-employee director compensation.
- Dowdy also serves on SPT Labtech board and advises EQT Life Sciences.

## SEC filing metadata
- accession: 0001140361-24-014618
- form_type: 8-K
- ticker: QSI
- cik: 0001816431
- company_name: Quantum-Si Inc
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816431/000114036124014618/0001140361-24-014618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816431/000114036124014618/ef20024742_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-014618
- JSON: https://secwatch.observer/filing/0001140361-24-014618.json
- Plain text: https://secwatch.observer/filing/0001140361-24-014618.txt

## Key facts
- Executive change
  Paula Dowdy was appointed as Director at Quantum-Si Inc.
  - Action: appointed
  - Role: Director
  source text: the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Paula Dowdy to the Board, effective as of March 21, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816431/000114036124014618/0001140361-24-014618-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.